These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32238835)

  • 21. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of blood clotting with the total thrombus analysis system in healthy dogs.
    Iwanaga T; Fukushima R; Nagasato T; Maruyama I; Miura N
    J Vet Diagn Invest; 2021 Mar; 33(2):357-361. PubMed ID: 33559534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
    Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
    Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much do you know about anticoagulant therapy?
    Wimberley P; Wiggins N
    Nurs Manage; 2004 Feb; 35(2):46-7. PubMed ID: 14767234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in antithrombotic agents.
    Chakrabarti R; Das SK
    Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):175-85. PubMed ID: 17630943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New targets for antithrombotic drugs.
    Thiagarajan P
    Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
    Raaz U; Kaeberich A; Maegdefessel L; Buerke M; Busshardt M; Schubert S; Russ M; Plehn A; Ebelt H; Werdan K; Schlitt A
    Thromb Haemost; 2010 Apr; 103(4):808-14. PubMed ID: 20174756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current pharmacological aspects of antithrombotic drugs].
    Stroescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):325-7. PubMed ID: 14367
    [No Abstract]   [Full Text] [Related]  

  • 31. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
    Muntean W
    Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic effects of naturally derived products on coagulation and platelet function.
    Mousa SA
    Methods Mol Biol; 2010; 663():229-40. PubMed ID: 20617421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis.
    Kawamura M; Konishi N; Hiroe K; Shofuda K; Imaeda Y; Fujimoto T; Kubo K
    J Cardiovasc Pharmacol; 2010 Aug; 56(2):156-61. PubMed ID: 20410831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic agents and invasive procedures--hematologist point of view.
    Lecompte TP
    Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
    Chu DC; Abu-Samra AG; Baird GL; Devers C; Sweeney J; Levy MM; Muratore CS; Ventetuolo CE
    Intensive Care Med; 2015 Feb; 41(2):369-70. PubMed ID: 25465907
    [No Abstract]   [Full Text] [Related]  

  • 37. Future Antithrombotic Therapies in Cardiology.
    Bäuml M; Hilgendorf I
    Hamostaseologie; 2018 Nov; 38(4):236-239. PubMed ID: 30267387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin, hemostasis, thrombosis, and coagulation.
    Keihanian F; Saeidinia A; Bagheri RK; Johnston TP; Sahebkar A
    J Cell Physiol; 2018 Jun; 233(6):4497-4511. PubMed ID: 29052850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antithrombotic activity of the active fractions from the fruits of Celastrus orbiculatus Thunb through the anti-coagulation, anti-platelet activation and anti-fibrinolysis pathways.
    Zhou J; Zhai J; Zheng W; Han N; Liu Z; Lv G; Zheng X; Chang S; Yin J
    J Ethnopharmacol; 2019 Sep; 241():111974. PubMed ID: 31132460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic therapy.
    Kazmier FJ
    Cardiovasc Clin; 1983; 13(2):321-33. PubMed ID: 6839327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.